Perceptive Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25,000
| Closed | -$355K | – | 126 |
|
|
2018
Q2 | $355K | Hold |
25,000
| – | – | 0.01% | 115 |
|
|
2018
Q1 | $475K | Buy |
+25,000
| New | +$475K | 0.01% | 118 |
|
|
2017
Q1 | – | Sell |
-272
| Closed | -$1K | – | 190 |
|
|
2016
Q4 | $1K | Hold |
272
| – | – | ﹤0.01% | 170 |
|
|
2016
Q3 | $1K | Buy |
+272
| New | +$1K | ﹤0.01% | 187 |
|
|
2015
Q3 | – | Sell |
-800,000
| Closed | -$8.87M | – | 169 |
|
|
2015
Q2 | $8.87M | Hold |
800,000
| – | – | 0.53% | 39 |
|
|
2015
Q1 | $12.5M | Hold |
800,000
| – | – | 0.97% | 28 |
|
|
2014
Q4 | $12.2M | Hold |
800,000
| – | – | 1.02% | 29 |
|
|
2014
Q3 | $8.63M | Hold |
800,000
| – | – | 0.87% | 29 |
|
|
2014
Q2 | $12.2M | Hold |
800,000
| – | – | 1.2% | 26 |
|
|
2014
Q1 | $14.5M | Buy |
+800,000
| New | +$14.5M | 1.52% | 19 |
|
|
2013
Q4 | – | Sell |
-965,000
| Closed | -$10.1M | – | 120 |
|
|
2013
Q3 | $10.1M | Buy |
+965,000
| New | +$10.1M | 0.82% | 29 |
|